chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza B virus test, International normalised ratio increased, Laboratory test, Limb discomfort, Metabolic function test abnormal
Clinical narrative: Woke up at 3:30am on Dec. 20,2021 with chest pain, heavy chest, arms and legs felt like concrete in them, short of breath and high blood pressure. Went to Medical Center ER. They ran blood work, have me meds thinking it might be indigestion and meds to bring blood pressure down. Rated chest pain 7-8. After labs were resulted ER doctor admitted to the hospital for observation. Was given more meds for blood pressure and chest pain and more labs were drawn. After being admitted for 12-14 hrs the heart enzymes had tripled, chest pain and blood pressure was still very high so transferred to higher level of care by ambulance. Admitted to hospital was given nitro and IV Heparin and observed for blood pressure and chest pain. After being there for 8 hours chest pain was down to 3-4 but still there and blood pressure was still elevated. Cardiac cath and ultrasound of the heart were ordered for the following morning. Cardiac cath showed nothing to indicate a heart attack, no obvious occlusive disease, LAD was somewhat tortious but it was felt he may have ether has a spasm or more like thrombus propagation, there were no blockages or anything to explain the symptoms, he had received the Johnson & Johnson vaccine a couple days prior to onset of symptoms. The ultrasound also was normal. no malfunctioning flaps. After cardiac cath the IV Heparin was discontinued. By now the chest was all but subsided. The internal medicine doctor nor the cardiologist had no explanation as to what or why this happened. They said they had had these symptoms from Covid vaccines but it usually younger men.  Discharge note- Will follow-up with cardiologist for heart monitor, possible MRI of heart and will go home on dual antiplatelet therapy.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Monocyte count increased, Myocardial necrosis marker increased, Prothrombin time prolonged, SARS-CoV-2 test negative, Troponin increased
Clinical narrative: Woke up at 3:30am on Dec. 20,2021 with chest pain, heavy chest, arms and legs felt like concrete in them, short of breath and high blood pressure. Went to Medical Center ER. They ran blood work, have me meds thinking it might be indigestion and meds to bring blood pressure down. Rated chest pain 7-8. After labs were resulted ER doctor admitted to the hospital for observation. Was given more meds for blood pressure and chest pain and more labs were drawn. After being admitted for 12-14 hrs the heart enzymes had tripled, chest pain and blood pressure was still very high so transferred to higher level of care by ambulance. Admitted to hospital was given nitro and IV Heparin and observed for blood pressure and chest pain. After being there for 8 hours chest pain was down to 3-4 but still there and blood pressure was still elevated. Cardiac cath and ultrasound of the heart were ordered for the following morning. Cardiac cath showed nothing to indicate a heart attack, no obvious occlusive disease, LAD was somewhat tortious but it was felt he may have ether has a spasm or more like thrombus propagation, there were no blockages or anything to explain the symptoms, he had received the Johnson & Johnson vaccine a couple days prior to onset of symptoms. The ultrasound also was normal. no malfunctioning flaps. After cardiac cath the IV Heparin was discontinued. By now the chest was all but subsided. The internal medicine doctor nor the cardiologist had no explanation as to what or why this happened. They said they had had these symptoms from Covid vaccines but it usually younger men.  Discharge note- Will follow-up with cardiologist for heart monitor, possible MRI of heart and will go home on dual antiplatelet therapy.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: White blood cell count increased
Clinical narrative: Woke up at 3:30am on Dec. 20,2021 with chest pain, heavy chest, arms and legs felt like concrete in them, short of breath and high blood pressure. Went to Medical Center ER. They ran blood work, have me meds thinking it might be indigestion and meds to bring blood pressure down. Rated chest pain 7-8. After labs were resulted ER doctor admitted to the hospital for observation. Was given more meds for blood pressure and chest pain and more labs were drawn. After being admitted for 12-14 hrs the heart enzymes had tripled, chest pain and blood pressure was still very high so transferred to higher level of care by ambulance. Admitted to hospital was given nitro and IV Heparin and observed for blood pressure and chest pain. After being there for 8 hours chest pain was down to 3-4 but still there and blood pressure was still elevated. Cardiac cath and ultrasound of the heart were ordered for the following morning. Cardiac cath showed nothing to indicate a heart attack, no obvious occlusive disease, LAD was somewhat tortious but it was felt he may have ether has a spasm or more like thrombus propagation, there were no blockages or anything to explain the symptoms, he had received the Johnson & Johnson vaccine a couple days prior to onset of symptoms. The ultrasound also was normal. no malfunctioning flaps. After cardiac cath the IV Heparin was discontinued. By now the chest was all but subsided. The internal medicine doctor nor the cardiologist had no explanation as to what or why this happened. They said they had had these symptoms from Covid vaccines but it usually younger men.  Discharge note- Will follow-up with cardiologist for heart monitor, possible MRI of heart and will go home on dual antiplatelet therapy.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Erythema, Flushing, Lacrimation increased
Clinical narrative: 1 hr and 45 min after vaccine complained of weird feeling in chest or heavy feeling and could not take deep breath and duration of 10 minutes. Also complained of teary and watery eyes, face flushed, and ears red. Pt took Benadryl 25mg.
Age: 54.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blindness, Ophthalmological examination abnormal, Visual impairment
Clinical narrative: After the first vaccine I noticed low vision. Now after two shots and a booster - my left eye is worse. Right eye has low vision. I am legally blind in 8 months.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Nasal congestion, Oropharyngeal pain
Clinical narrative: Narrative: COVID infection following COVID vaccine series and after previous COVID infection 2/12, Pfizer, dose #1 03/04, Pfizer, dose #2 01/10 COVID swab, result: detected 01/03 pt cc: runny nose, fever, sore throat, Nasal congestion, and cough exposure: unknown 01/03 pt admit ED cc: runny nose, fever, sore throat, Nasal congestion, and cough dx: Positive Covid LOS: 1 day 01/03 CXR impression: No acute cardiopulmonary disease. 01/10 pt admit ED cc/; symptoms are improving she has been without fever for 24 hours dx: COVID-19 retest LOS: 1 day 01/10 COVID swab, result: detected
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series and after previous COVID infection 2/12, Pfizer, dose #1 03/04, Pfizer, dose #2 01/10 COVID swab, result: detected 01/03 pt cc: runny nose, fever, sore throat, Nasal congestion, and cough exposure: unknown 01/03 pt admit ED cc: runny nose, fever, sore throat, Nasal congestion, and cough dx: Positive Covid LOS: 1 day 01/03 CXR impression: No acute cardiopulmonary disease. 01/10 pt admit ED cc/; symptoms are improving she has been without fever for 24 hours dx: COVID-19 retest LOS: 1 day 01/10 COVID swab, result: detected
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Narrative: 46 yo patient recieved Moderna COVID-19 vaccine first dose 3/18/21 and second dose 4/15/21. At PCP follow up 1/19/22, patient reported he had developed shingles after the vaccine, potentially two cases, around June 2021 and August 2021 for which he was treated with valacyclovir at an outside facility. Patient offered shingles vaccine and plans to get shingles vaccine at next visit.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Narrative: 11/02 COVID vaccine dose#1 11/03 seen in ED with c/o facial hives; no information provided regarding treatment, not admitted 11/12 seen by PCP, symptoms not mentioned, likely resolved
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chills, Cough
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/02, Pfizer, dose #1 04/23, Pfizer, dose #2 12/27 COVID swab, result: detected 1/3 COVID swab, result: detected 12/19 pt cc: chills, cough, diarrhea, fatigue fever, headache,  loss of taste or smell dyspnea exposure: unknown
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Fatigue, Headache, Pyrexia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/02, Pfizer, dose #1 04/23, Pfizer, dose #2 12/27 COVID swab, result: detected 1/3 COVID swab, result: detected 12/19 pt cc: chills, cough, diarrhea, fatigue fever, headache,  loss of taste or smell dyspnea exposure: unknown
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 04/02, Pfizer, dose #1 04/23, Pfizer, dose #2 12/27 COVID swab, result: detected 1/3 COVID swab, result: detected 12/19 pt cc: chills, cough, diarrhea, fatigue fever, headache,  loss of taste or smell dyspnea exposure: unknown
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Fatigue
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19. Pfizer, dose #1 (non-VA) 04/05, Pfizer, dose #2 (non-VA) 1/4 COVID swab, result: detected 12/26 pt cc: chills, cough, diarrhea, fatigue, fever, headache, myalgias, nausea, dyspnea exposure: unknown 12/31 clinically resolved
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 03/19. Pfizer, dose #1 (non-VA) 04/05, Pfizer, dose #2 (non-VA) 1/4 COVID swab, result: detected 12/26 pt cc: chills, cough, diarrhea, fatigue, fever, headache, myalgias, nausea, dyspnea exposure: unknown 12/31 clinically resolved
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Fatigue, Headache
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/16, Pfizer, dose #1 05/10, Pfizer, dose #2 12/27 COVID swab, result: detected 12/27 pt cc: chills, cough, fatigue, headache, myalgias, rhinorrhea, exposure: unknown 12/30 clinically resolved
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 04/16, Pfizer, dose #1 05/10, Pfizer, dose #2 12/27 COVID swab, result: detected 12/27 pt cc: chills, cough, fatigue, headache, myalgias, rhinorrhea, exposure: unknown 12/30 clinically resolved
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Myalgia, Nasal congestion, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 08/17, Pfizer, dose #1 10/27, Pfizer, dose#2 COVID swab, result: detected 12/25 pt cc: chills, myalgia, nasal congestion, exposure: unknown clinically resolved
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Dyspnoea, Headache, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/082, Pfizer, dose #1 03/27, Pfizer, dose #2 11/23, Pfizer, dose #3 12/27 COVID swab, result: detected 12/25 pt cc: cough, rhinorrhea, headache, myalgias, dyspnea, sore throat exposure: unknown
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/082, Pfizer, dose #1 03/27, Pfizer, dose #2 11/23, Pfizer, dose #3 12/27 COVID swab, result: detected 12/25 pt cc: cough, rhinorrhea, headache, myalgias, dyspnea, sore throat exposure: unknown
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Headache, Nausea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/24, Pfizer, dose #1 04/14, Pfizer, dose #2 12/27 COVID swab, result: detected 12/17 pt cc: nausea, headache exposure: unknown
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: Narrative:  COVID infection following COVID vaccine series 09/09, Pfizer, dose #1 09/30, Pfizer, dose #2 12/27 COVID Swab, result: detected 1/3 COVID Swab, result: detected 12/26 pt cc: cough, exposure: unknown 12/31 clinically resolved
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Exposure to SARS-CoV-2, Fatigue, Myalgia
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/04, Pfizer, dose #1 02/22, Pfizer, dose #2 11/12, Pfizer, dose 3 12/27 COVID swab, result: detected 12/27 pt cc: cough, fatigue myalgias, sore throat, exposure, family
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 02/04, Pfizer, dose #1 02/22, Pfizer, dose #2 11/12, Pfizer, dose 3 12/27 COVID swab, result: detected 12/27 pt cc: cough, fatigue myalgias, sore throat, exposure, family
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: Given a low dose (0.2 ml) instead of (0.3 ml) PFIZER Covid vaccine 1st dose.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acute myocardial infarction, Anticoagulant therapy, Aortic stenosis, Aortic valve thickening, Bundle branch block left
Clinical narrative: Patient received covid 19 moderna vaccine on 1/29 and 2/26/21. Patient presented to facility on 3/2/21 with DOE for 4 months. Patient states after the second dose of covid vaccine, she developed chills and acute onset SOB the day after. EKG showed LBBB, resolved on admission. Given c/f NSTEMI, patient received AC with heparin drip and underwent LHC on 3/5. Due to persistent troponemia, she underwent cardiac MRI on 3/7:    1. The left ventricular size is mildly dilated (LVEDVI = 86 ml/m^2) . The left ventricular ejection fraction is 36 % by method. Global left ventricular function is moderately decreased. The left ventricular wall is diffusely hypokinetic. The left ventricular mass is mildly increased.   2. There is no resting first pass myocardial perfusion defect. There is a small amount of late gadolinium enhancement at the true apex likely indicative of fibrosis. The extracellular volume (ECV) is normal, measuring 26-28%. The native T1 mapping times are 1189 msec (normal 1200+/- 80 msec).  3. The right ventricular size is normal. Global right ventricular function is normal. The right ventricle ejection fraction is 57%. There are no regional wall motion abnormalities of the right ventricular wall.   4. Left atrial size is normal. Right atrial size is normal. Lipomatous hypertrophy of the atrial septum.   5. The aortic valve is thickened with restricted leaflet motion consistent with aortic stenosis.  The severity of the stenosis could not be assessed. The anterior leaflet of the mitral valve is thickened.   6. Incompletely characterized 3 cm lesion in the left kidney inferior pole. Recommend imaging with renal ultrasound for further evaluation.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: C-reactive protein increased, Cardiac imaging procedure abnormal, Cardiac steatosis, Chills, Dyspnoea exertional
Clinical narrative: Patient received covid 19 moderna vaccine on 1/29 and 2/26/21. Patient presented to facility on 3/2/21 with DOE for 4 months. Patient states after the second dose of covid vaccine, she developed chills and acute onset SOB the day after. EKG showed LBBB, resolved on admission. Given c/f NSTEMI, patient received AC with heparin drip and underwent LHC on 3/5. Due to persistent troponemia, she underwent cardiac MRI on 3/7:    1. The left ventricular size is mildly dilated (LVEDVI = 86 ml/m^2) . The left ventricular ejection fraction is 36 % by method. Global left ventricular function is moderately decreased. The left ventricular wall is diffusely hypokinetic. The left ventricular mass is mildly increased.   2. There is no resting first pass myocardial perfusion defect. There is a small amount of late gadolinium enhancement at the true apex likely indicative of fibrosis. The extracellular volume (ECV) is normal, measuring 26-28%. The native T1 mapping times are 1189 msec (normal 1200+/- 80 msec).  3. The right ventricular size is normal. Global right ventricular function is normal. The right ventricle ejection fraction is 57%. There are no regional wall motion abnormalities of the right ventricular wall.   4. Left atrial size is normal. Right atrial size is normal. Lipomatous hypertrophy of the atrial septum.   5. The aortic valve is thickened with restricted leaflet motion consistent with aortic stenosis.  The severity of the stenosis could not be assessed. The anterior leaflet of the mitral valve is thickened.   6. Incompletely characterized 3 cm lesion in the left kidney inferior pole. Recommend imaging with renal ultrasound for further evaluation.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ejection fraction decreased, Electrocardiogram abnormal, Fibrosis, Left ventricular dilatation, Left ventricular dysfunction
Clinical narrative: Patient received covid 19 moderna vaccine on 1/29 and 2/26/21. Patient presented to facility on 3/2/21 with DOE for 4 months. Patient states after the second dose of covid vaccine, she developed chills and acute onset SOB the day after. EKG showed LBBB, resolved on admission. Given c/f NSTEMI, patient received AC with heparin drip and underwent LHC on 3/5. Due to persistent troponemia, she underwent cardiac MRI on 3/7:    1. The left ventricular size is mildly dilated (LVEDVI = 86 ml/m^2) . The left ventricular ejection fraction is 36 % by method. Global left ventricular function is moderately decreased. The left ventricular wall is diffusely hypokinetic. The left ventricular mass is mildly increased.   2. There is no resting first pass myocardial perfusion defect. There is a small amount of late gadolinium enhancement at the true apex likely indicative of fibrosis. The extracellular volume (ECV) is normal, measuring 26-28%. The native T1 mapping times are 1189 msec (normal 1200+/- 80 msec).  3. The right ventricular size is normal. Global right ventricular function is normal. The right ventricle ejection fraction is 57%. There are no regional wall motion abnormalities of the right ventricular wall.   4. Left atrial size is normal. Right atrial size is normal. Lipomatous hypertrophy of the atrial septum.   5. The aortic valve is thickened with restricted leaflet motion consistent with aortic stenosis.  The severity of the stenosis could not be assessed. The anterior leaflet of the mitral valve is thickened.   6. Incompletely characterized 3 cm lesion in the left kidney inferior pole. Recommend imaging with renal ultrasound for further evaluation.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging heart, Mitral valve thickening, Red blood cell sedimentation rate increased, Renal neoplasm, Troponin T increased
Clinical narrative: Patient received covid 19 moderna vaccine on 1/29 and 2/26/21. Patient presented to facility on 3/2/21 with DOE for 4 months. Patient states after the second dose of covid vaccine, she developed chills and acute onset SOB the day after. EKG showed LBBB, resolved on admission. Given c/f NSTEMI, patient received AC with heparin drip and underwent LHC on 3/5. Due to persistent troponemia, she underwent cardiac MRI on 3/7:    1. The left ventricular size is mildly dilated (LVEDVI = 86 ml/m^2) . The left ventricular ejection fraction is 36 % by method. Global left ventricular function is moderately decreased. The left ventricular wall is diffusely hypokinetic. The left ventricular mass is mildly increased.   2. There is no resting first pass myocardial perfusion defect. There is a small amount of late gadolinium enhancement at the true apex likely indicative of fibrosis. The extracellular volume (ECV) is normal, measuring 26-28%. The native T1 mapping times are 1189 msec (normal 1200+/- 80 msec).  3. The right ventricular size is normal. Global right ventricular function is normal. The right ventricle ejection fraction is 57%. There are no regional wall motion abnormalities of the right ventricular wall.   4. Left atrial size is normal. Right atrial size is normal. Lipomatous hypertrophy of the atrial septum.   5. The aortic valve is thickened with restricted leaflet motion consistent with aortic stenosis.  The severity of the stenosis could not be assessed. The anterior leaflet of the mitral valve is thickened.   6. Incompletely characterized 3 cm lesion in the left kidney inferior pole. Recommend imaging with renal ultrasound for further evaluation.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ventricular hypokinesia
Clinical narrative: Patient received covid 19 moderna vaccine on 1/29 and 2/26/21. Patient presented to facility on 3/2/21 with DOE for 4 months. Patient states after the second dose of covid vaccine, she developed chills and acute onset SOB the day after. EKG showed LBBB, resolved on admission. Given c/f NSTEMI, patient received AC with heparin drip and underwent LHC on 3/5. Due to persistent troponemia, she underwent cardiac MRI on 3/7:    1. The left ventricular size is mildly dilated (LVEDVI = 86 ml/m^2) . The left ventricular ejection fraction is 36 % by method. Global left ventricular function is moderately decreased. The left ventricular wall is diffusely hypokinetic. The left ventricular mass is mildly increased.   2. There is no resting first pass myocardial perfusion defect. There is a small amount of late gadolinium enhancement at the true apex likely indicative of fibrosis. The extracellular volume (ECV) is normal, measuring 26-28%. The native T1 mapping times are 1189 msec (normal 1200+/- 80 msec).  3. The right ventricular size is normal. Global right ventricular function is normal. The right ventricle ejection fraction is 57%. There are no regional wall motion abnormalities of the right ventricular wall.   4. Left atrial size is normal. Right atrial size is normal. Lipomatous hypertrophy of the atrial septum.   5. The aortic valve is thickened with restricted leaflet motion consistent with aortic stenosis.  The severity of the stenosis could not be assessed. The anterior leaflet of the mitral valve is thickened.   6. Incompletely characterized 3 cm lesion in the left kidney inferior pole. Recommend imaging with renal ultrasound for further evaluation.
Age: 77.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Blood test abnormal, Myalgia, Polymyalgia rheumatica
Clinical narrative: Pt. states that after receiving the 1st dose of Shingrix 08/16/2021, started experiencing symptoms 08/20/2021 of joint and muscle pain. 08/2021 Primary visit, Diagnosed with Polymyalgia rheumatica with treatment of Prednisone steroids. Continuous use 12+/symptoms have subsided with use.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Blood glucose normal, Chronic sinusitis, Computerised tomogram head abnormal, Dizziness, Electroencephalogram normal
Clinical narrative: Patient had acute vomiting episode with dizziness in the bathroom of the office shortly after receiving the vaccine.  Also, mom reports seizure like activity on the way home from the doctor's office that day.  Also at 1700 that day he exhibited seizure like activity again.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Seizure like phenomena, Vomiting
Clinical narrative: Patient had acute vomiting episode with dizziness in the bathroom of the office shortly after receiving the vaccine.  Also, mom reports seizure like activity on the way home from the doctor's office that day.  Also at 1700 that day he exhibited seizure like activity again.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: Suspect COVID breakthrough case Admitted for DVT, PE, lung mass, retroperitoneal hematoma
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Pulmonary embolism, Pulmonary mass, Retroperitoneal haematoma, Suspected COVID-19
Clinical narrative: Suspect COVID breakthrough case Admitted for DVT, PE, lung mass, retroperitoneal hematoma
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vaccine breakthrough infection
Clinical narrative: Suspect COVID breakthrough case Admitted for DVT, PE, lung mass, retroperitoneal hematoma
Age: 11.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Chronic hives. He is on 4 weeks of these hives.  They have interrupted him being able to go to school and me go to work so I can care for my child. These hives cover his entire body and  he?s miserable. They started the exact day after the Covid shot. Many blood tests have proved he?s like this due to his auto immune disease and the shot.
Age: 11.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Autoimmune disorder, Blood test abnormal, Feeling abnormal, Laboratory test, Loss of personal independence in daily activities
Clinical narrative: Chronic hives. He is on 4 weeks of these hives.  They have interrupted him being able to go to school and me go to work so I can care for my child. These hives cover his entire body and  he?s miserable. They started the exact day after the Covid shot. Many blood tests have proved he?s like this due to his auto immune disease and the shot.
Age: 11.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Urticaria, Vaccination complication
Clinical narrative: Chronic hives. He is on 4 weeks of these hives.  They have interrupted him being able to go to school and me go to work so I can care for my child. These hives cover his entire body and  he?s miserable. They started the exact day after the Covid shot. Many blood tests have proved he?s like this due to his auto immune disease and the shot.
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Autonomic nervous system imbalance, Chest pain, Dyspnoea, Echocardiogram normal
Clinical narrative: Experienced flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Experienced flu symptoms) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), VITAMIN B NOS and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced INFLUENZA LIKE ILLNESS (Experienced flu symptoms). The patient was treated with FLUDROCORTISONE at an unspecified dose and frequency; METOPROLOL TARTRATE at an unspecified dose and frequency; THIAMINE at an unspecified dose and frequency; CALCIUM ACETATE at an unspecified dose and frequency; ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) at an unspecified dose and frequency; PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. In April 2021, INFLUENZA LIKE ILLNESS (Experienced flu symptoms) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No medical history was reported. The patient experienced symptoms for around three weeks, after that patient got better.   This case was linked to MOD-2022-473822 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electric shock sensation, Electrocardiogram, Fatigue, Feeling abnormal, Heart rate irregular
Clinical narrative: Experienced flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Experienced flu symptoms) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), VITAMIN B NOS and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced INFLUENZA LIKE ILLNESS (Experienced flu symptoms). The patient was treated with FLUDROCORTISONE at an unspecified dose and frequency; METOPROLOL TARTRATE at an unspecified dose and frequency; THIAMINE at an unspecified dose and frequency; CALCIUM ACETATE at an unspecified dose and frequency; ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) at an unspecified dose and frequency; PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. In April 2021, INFLUENZA LIKE ILLNESS (Experienced flu symptoms) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No medical history was reported. The patient experienced symptoms for around three weeks, after that patient got better.   This case was linked to MOD-2022-473822 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypotension, Insomnia, Magnetic resonance imaging head normal, Malaise, Muscle spasms
Clinical narrative: Experienced flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Experienced flu symptoms) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), VITAMIN B NOS and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced INFLUENZA LIKE ILLNESS (Experienced flu symptoms). The patient was treated with FLUDROCORTISONE at an unspecified dose and frequency; METOPROLOL TARTRATE at an unspecified dose and frequency; THIAMINE at an unspecified dose and frequency; CALCIUM ACETATE at an unspecified dose and frequency; ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) at an unspecified dose and frequency; PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. In April 2021, INFLUENZA LIKE ILLNESS (Experienced flu symptoms) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No medical history was reported. The patient experienced symptoms for around three weeks, after that patient got better.   This case was linked to MOD-2022-473822 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations, Paraesthesia, Peripheral swelling, Postural orthostatic tachycardia syndrome, Scan with contrast normal
Clinical narrative: Experienced flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Experienced flu symptoms) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), VITAMIN B NOS and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced INFLUENZA LIKE ILLNESS (Experienced flu symptoms). The patient was treated with FLUDROCORTISONE at an unspecified dose and frequency; METOPROLOL TARTRATE at an unspecified dose and frequency; THIAMINE at an unspecified dose and frequency; CALCIUM ACETATE at an unspecified dose and frequency; ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) at an unspecified dose and frequency; PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. In April 2021, INFLUENZA LIKE ILLNESS (Experienced flu symptoms) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No medical history was reported. The patient experienced symptoms for around three weeks, after that patient got better.   This case was linked to MOD-2022-473822 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sleep disorder, Tenderness, Tilt table test positive, Tremor
Clinical narrative: Experienced flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Experienced flu symptoms) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), VITAMIN B NOS and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced INFLUENZA LIKE ILLNESS (Experienced flu symptoms). The patient was treated with FLUDROCORTISONE at an unspecified dose and frequency; METOPROLOL TARTRATE at an unspecified dose and frequency; THIAMINE at an unspecified dose and frequency; CALCIUM ACETATE at an unspecified dose and frequency; ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) at an unspecified dose and frequency; PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. In April 2021, INFLUENZA LIKE ILLNESS (Experienced flu symptoms) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No medical history was reported. The patient experienced symptoms for around three weeks, after that patient got better.   This case was linked to MOD-2022-473822 (Patient Link).
Age: 38.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Influenza like illness
Clinical narrative: Experienced flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Experienced flu symptoms) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), VITAMIN B NOS and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced INFLUENZA LIKE ILLNESS (Experienced flu symptoms). The patient was treated with FLUDROCORTISONE at an unspecified dose and frequency; METOPROLOL TARTRATE at an unspecified dose and frequency; THIAMINE at an unspecified dose and frequency; CALCIUM ACETATE at an unspecified dose and frequency; ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL, SALICYLAMIDE (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL;SALICYLAMIDE]) at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; BISMUTH SUBSALICYLATE, CALCIUM CARBONATE (PEPTO BISMOL [BISMUTH SUBSALICYLATE;CALCIUM CARBONATE]) at an unspecified dose and frequency; PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. In April 2021, INFLUENZA LIKE ILLNESS (Experienced flu symptoms) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No medical history was reported. The patient experienced symptoms for around three weeks, after that patient got better.   This case was linked to MOD-2022-473822 (Patient Link).
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Electrocardiogram abnormal, Pericarditis, Troponin increased
Clinical narrative: Chest pain started 2/5/2022. The following morning (2/6/2022) he took antacids and the pain subsided. Admitted to the hospital on 2/6 for elevated troponin and ST changes.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Adenovirus test, C-reactive protein increased, Chest pain, Chlamydia test negative, Cytomegalovirus test negative
Clinical narrative: Chest pain started 2/5/2022. The following morning (2/6/2022) he took antacids and the pain subsided. Admitted to the hospital on 2/6 for elevated troponin and ST changes.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Echocardiogram normal, Electrocardiogram ST segment abnormal, Enterovirus test negative, Epstein-Barr virus test negative, HIV test negative
Clinical narrative: Chest pain started 2/5/2022. The following morning (2/6/2022) he took antacids and the pain subsided. Admitted to the hospital on 2/6 for elevated troponin and ST changes.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hepatitis B virus test, Herpes simplex test negative, Human metapneumovirus test, Human rhinovirus test, Influenza virus test negative
Clinical narrative: Chest pain started 2/5/2022. The following morning (2/6/2022) he took antacids and the pain subsided. Admitted to the hospital on 2/6 for elevated troponin and ST changes.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Laboratory test normal, Mycoplasma test negative, Respiratory syncytial virus test negative, Respirovirus test, SARS-CoV-2 test negative
Clinical narrative: Chest pain started 2/5/2022. The following morning (2/6/2022) he took antacids and the pain subsided. Admitted to the hospital on 2/6 for elevated troponin and ST changes.
Age: 15.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Troponin increased
Clinical narrative: Chest pain started 2/5/2022. The following morning (2/6/2022) he took antacids and the pain subsided. Admitted to the hospital on 2/6 for elevated troponin and ST changes.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Administered booster dose of Moderna twenty two days early from second dose as a result of mistaking the second dose written date as 8/30/2021 instead 9/30/2021.
Age: 38.0
Sex: F
Vaccine: UNK
Symptoms: Chills, Nausea, Pain, Pyrexia
Clinical narrative: 12 hours After second dose I had fever, body aches, chills and nausea that lasted approximately 12 hours.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, Exposure during pregnancy, Haemorrhage, Ultrasound antenatal screen abnormal
Clinical narrative: Pregnancy loss/miscarriage following receiving second COVID vaccine dose
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Autoimmune thyroid disorder, Laboratory test abnormal, Palpitations, Panic attack
Clinical narrative: I had palpitations and they would come and go and then I kept having them like panic attacks and I had some labs and it was thyroid autoimmune but I never had those symptoms before I had them the day of the vaccine the 15 minutes that I had to wait their I started having palpitations in the clinic and they had me wait their for an hour but I still keep on having panic attacks since I had tha vaccine
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Inappropriate schedule of product administration
Clinical narrative: Patient came in for a second dose of Moderna. When we went into system to document we discovered she received a dose in March 2021 and was told by her physician to restart the series. Her card only had a dose received December 29, 2021. According to her record she has received three .50 ml's of Moderna. Please advice.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus. There is constant high pitch ringing in my ears. The only variable throughout each day is the intensity of the ringing.
Age: 1.0
Sex: F
Vaccine: FLUC4, HEPA, MMR, VARCEL
Symptoms: Decreased appetite, Insomnia, Irritability, Pyrexia, Tachycardia
Clinical narrative: 2/9: 11:00am - Onset of high fever (103F), no appetite, moderate fussiness, difficult sleeping, tachycardia (145-178bpm) overnight.  2/10: Fever off and on with poor appetite and fussiness. 103 fever at bedtime. (HR 135-172bpm) while sleeping.
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: Patient did not experience and adverse event to the vaccine.  The patient is less than 18 years old, and inadvertently received Moderna as her third (booster) dose.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Patient did not experience an adverse event. Upon documentation, it was realized this patient received a fourth dose, although they did not have an indication to receive a fourth dose.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Encephalopathy, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Patient received Pfizer COVID vaccine on 1/30/21 and 2/26/21. On 2/8/22, patient admitted to our inpatient facility after dialysis session with acute encephalopathy likely secondary to acute viral syndrome/COVID pneumonia with fever and positive COVID status. As of today (2/10/22), patient is still admitted in our med/surg unit.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Viral infection
Clinical narrative: Patient received Pfizer COVID vaccine on 1/30/21 and 2/26/21. On 2/8/22, patient admitted to our inpatient facility after dialysis session with acute encephalopathy likely secondary to acute viral syndrome/COVID pneumonia with fever and positive COVID status. As of today (2/10/22), patient is still admitted in our med/surg unit.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Inappropriate schedule of product administration, Melaena
Clinical narrative: Patient received Pfizer COVID vaccine on 3/20/21 (lot # ER2613), 4/27/21 (lot # ER8731), and 8/25/21 (lot # FC31836). On 2/9/22, patient admitted to our inpatient facility with COVID19 pneumonia, acute hypoxic respiratory failure, and reported melena. As of today (2/10/22), patient is still admitted in our med/surg unit.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Patient received Pfizer COVID vaccine on 3/20/21 (lot # ER2613), 4/27/21 (lot # ER8731), and 8/25/21 (lot # FC31836). On 2/9/22, patient admitted to our inpatient facility with COVID19 pneumonia, acute hypoxic respiratory failure, and reported melena. As of today (2/10/22), patient is still admitted in our med/surg unit.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Illness, Intermenstrual bleeding, Menstruation irregular, Pain in extremity
Clinical narrative: After the usual signs of pain in my arm and sickness the next couple days, I was starting to get my period and I could tell things were different.  I had early spotting, and it was stretched out for longer days. I normally have spotting one day, a bad day or two or bleeding, then done. But I was having many days of spotting before I would bleed, which is weird for me. Also, my periods got way more painful, and still are more painful. The past 6 months I've had the most painful periods of my life. Lastly, I still get phantom arm pain where the needle was, which is super strange to me. It will feel like I got my shot yesterday sometimes, even though it's been months.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Phantom limb syndrome
Clinical narrative: After the usual signs of pain in my arm and sickness the next couple days, I was starting to get my period and I could tell things were different.  I had early spotting, and it was stretched out for longer days. I normally have spotting one day, a bad day or two or bleeding, then done. But I was having many days of spotting before I would bleed, which is weird for me. Also, my periods got way more painful, and still are more painful. The past 6 months I've had the most painful periods of my life. Lastly, I still get phantom arm pain where the needle was, which is super strange to me. It will feel like I got my shot yesterday sometimes, even though it's been months.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Autoimmune disorder, Cough, Dyspnoea, Ear discomfort, Ear swelling
Clinical narrative: Developed swollen burning itching of left ear around 3rd week of November. Developed trouble breathing, inhaling, caugh early January 2022. Saw dermatologist 12/14, saw primary doctor 12/22. Saw ENT 1/4/22. Saw primary doctor 1/10. Saw ENT 1/14. Saw ENT 2/8
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Polychondritis, Pruritus
Clinical narrative: Developed swollen burning itching of left ear around 3rd week of November. Developed trouble breathing, inhaling, caugh early January 2022. Saw dermatologist 12/14, saw primary doctor 12/22. Saw ENT 1/4/22. Saw primary doctor 1/10. Saw ENT 1/14. Saw ENT 2/8
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, COVID-19 pneumonia, Cardiac failure congestive, Condition aggravated
Clinical narrative: Patient received Pfizer COVID vaccine on 9/24/21 and 10/16/21. On 2/9/22, patient admitted to our inpatient facility with acute hypoxemic respiratory failure due to acute on chronic combined systolic and diastolic congestive heart failure in the setting of end-stage renal disease with missing dialysis sessions and COVID pneumonia. As of today (2/10/22), patient is still admitted in our med/surg unit.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: End stage renal disease, Inappropriate schedule of product administration, Left ventricular failure, SARS-CoV-2 test positive, Treatment noncompliance
Clinical narrative: Patient received Pfizer COVID vaccine on 9/24/21 and 10/16/21. On 2/9/22, patient admitted to our inpatient facility with acute hypoxemic respiratory failure due to acute on chronic combined systolic and diastolic congestive heart failure in the setting of end-stage renal disease with missing dialysis sessions and COVID pneumonia. As of today (2/10/22), patient is still admitted in our med/surg unit.